Test Code SLO Smith-Lemli-Opitz Screen, Plasma
Performing Laboratory
Mayo Clinic Laboratories in RochesterReporting Name
Smith-Lemli-Opitz Scrn, PSpecimen Type
PlasmaNecessary Information
Biochemical Genetics Patient Information (T602) is recommended, but not required, to be filled out and sent with the specimen to aid in the interpretation of test results.
Specimen Required
Collection Container/Tube:
Preferred: Green top (sodium or lithium heparin)
Acceptable: Lavender top (EDTA), pearl white top (EDTA plasma gel), yellow top (ACD solution A or B)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Centrifuge and aliquot plasma into plastic vial.
2. Send plasma frozen.
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma | Frozen (preferred) | 92 days | |
Refrigerated | 28 days | ||
Ambient | 14 days |
Specimen Minimum Volume
0.1 mL
Special Instructions
Day(s) Performed
Tuesday, Friday
Specimen Retention Time
1 monthReport Available
3 to 7 daysReference Values
7-DEHYDROCHOLESTEROL
≤2.0 mg/L
8-DEHYDROCHOLESTEROL
≤0.3 mg/L
Useful For
Diagnosing Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency)
CPT Code Information
82542
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
SLO | Smith-Lemli-Opitz Scrn, P | 73852-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
29972 | Interpretation | 59462-2 |
610625 | 7-Dehydrocholesterol | 33275-9 |
610626 | 8-Dehydrocholesterol | 34671-8 |
29974 | Reviewed By | 18771-6 |
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.
Genetics Test Information
Smith-Lemli-Opitz syndrome (SLO) is a multiple congenital anomaly disorder caused by defective cholesterol biosynthesis due to deficiency of the enzyme 7-dehydrocholesterol (7-DHC) reductase.
Clinical variability even within families has been noted and severity of SLO ranges from severe to mild.
Elevated plasma concentrations of 7-DHC and 8-dehydrocholesterol are highly suggestive of a biochemical diagnosis of SLO.